We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$270M
AUM Growth
-$29.4M
Cap. Flow
-$45.9M
Cap. Flow %
-17.01%
Top 10 Hldgs %
39.46%
Holding
110
New
22
Increased
25
Reduced
44
Closed
14

Top Buys

Rank Stock Value
1
AMSG
Amsurg Corp
AMSG
+$10.3M
2
ESRX
Express Scripts Holding Company
ESRX
+$3.67M
3
AKRX
Akorn Inc
AKRX
+$3.38M
4
SHPG
Shire pic
SHPG
+$3.35M
5
HCA icon
HCA Healthcare
HCA
+$3.33M

Top Sells

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$8.81M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$8.25M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.07M
4
EHC icon
Encompass Health
EHC
+$5.04M
5
BDX icon
Becton Dickinson
BDX
+$4.8M

Sector Composition

Rank Sector Weight
1 Healthcare 87.33%
2 Financials 3.58%
3 Industrials 1.13%
4 Energy 0.58%
5 Technology 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCR
26
DELISTED
CR Bard Inc.
BCR
$3.55M 1.32%
15,827
+14,209
+878% +$3.2M
CELG
27
DELISTED
Celgene Corp
CELG
$3.5M 1.3%
33,480
+10,600
+46% +$1.15M
VTRS icon
28
Viatris
VTRS
$20.4B
$3.47M 1.29%
90,974
+53,450
+142% +$2.38M
TMO icon
29
Thermo Fisher Scientific
TMO
$213B
$3.29M 1.22%
20,686
-31,000
-60% -$4.78M
AKRX
30
DELISTED
Akorn Inc
AKRX
$3.11M 1.15%
+114,100
New +$3.38M
VWR
31
DELISTED
VWR Corporation
VWR
$3.05M 1.13%
107,422
+25,333
+31% +$734K
CRL icon
32
Charles River Laboratories
CRL
$11.2B
$2.98M 1.11%
35,788
-4,300
-11% -$360K
AMAG
33
DELISTED
AMAG Pharmaceuticals
AMAG
$2.82M 1.04%
114,980
+42,600
+59% +$1.06M
CVS icon
34
CVS Health
CVS
$133B
$2.64M 0.98%
29,683
+18,298
+161% +$1.73M
ENDP
35
DELISTED
Endo International plc
ENDP
$2.19M 0.81%
+108,696
New +$2.16M
JNJ icon
36
Johnson & Johnson
JNJ
$618B
$2M 0.74%
16,900
-7,600
-31% -$922K
GILD icon
37
Gilead Sciences
GILD
$162B
$1.65M 0.61%
20,810
-7,000
-25% -$569K
AERI
38
DELISTED
Aerie Pharmaceuticals
AERI
$1.59M 0.59%
42,030
+8,630
+26% +$190K
CNMD icon
39
CONMED
CNMD
$1.39B
$1.58M 0.59%
+39,500
New +$1.68M
LHCG
40
DELISTED
LHC Group LLC
LHCG
$1.57M 0.58%
42,700
-29,500
-41% -$1.18M
A icon
41
Agilent Technologies
A
$39.1B
$1.44M 0.53%
30,585
-59,900
-66% -$2.8M
OXFD
42
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.4M 0.52%
+111,655
New +$1.12M
PRGO icon
43
Perrigo
PRGO
$1.4B
$1.39M 0.52%
15,100
+7,500
+99% +$691K
NSTG
44
DELISTED
NanoString Technologies, Inc.
NSTG
$1.39M 0.52%
69,574
-137,894
-66% -$2.19M
NVRO
45
DELISTED
NEVRO CORP.
NVRO
$1.31M 0.49%
12,584
-28,900
-70% -$2.61M
AMGN icon
46
Amgen
AMGN
$208B
$1.31M 0.49%
7,858
-18,442
-70% -$3.12M
SPNC
47
DELISTED
Spectranetics Corp
SPNC
$1.3M 0.48%
52,026
-191,600
-79% -$4.47M
HRC
48
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.19M 0.44%
19,200
-16,400
-46% -$924K
CTLT
49
DELISTED
CATALENT, INC.
CTLT
$1.19M 0.44%
46,000
+5,600
+14% +$139K
XRAY icon
50
Dentsply Sirona
XRAY
$2.68B
$1.12M 0.42%
+18,900
New +$1.16M
1
2
3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Endurant Capital Management held 110 positions worth $270M, down 9.8% from $299M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Endurant Capital Management withdrew a net $45.9M in Q3 2016, closing 14 positions and reducing 44 holdings. Its most notable exit was Standard BioTools, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.

Against the trend, Endurant Capital Management opened a new position in Amsurg Corp worth $9.89M.

  • Endurant Capital Management's largest Q3 2016 buy was Amsurg Corp: 147,500 shares worth $9.89M.
  • Endurant Capital Management added most to Express Scripts Holding Company in Q3 2016, an estimated $3.67M increase.
  • Endurant Capital Management's biggest Q3 2016 reduction was Wright Medical Group Inc, cutting an estimated $8.81M.
  • Endurant Capital Management fully exited Standard BioTools in Q3 2016, selling an estimated $2.32M.
  • Endurant Capital Management's ten largest holdings make up 39% of its $270M portfolio in Q3 2016.
  • Endurant Capital Management opened 22 new positions and closed 14 in Q3 2016.
  • Endurant Capital Management's portfolio value fell 9.8% quarter-over-quarter to $270M.

Based on Endurant Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.